|
Climb MCADD Conference 2013 in Northampton funded by the Charlie Mortimer Trust |
|
|
Research Funded by Climb
When Climb was founded way back in 1981 (as the Research Trust for Metabolic Diseases in Children), research was a key objective for the charity and it remains so today. Since then we have funded research into over sixty different metabolic diseases through over 130 different research projects and to a value of more than £1.05m. This is an achievement of which Climb is rightly very proud. The first project grant from Climb was made in 1982 with a value of £1,000 for an enzyme transfer project. More recent projects have included research into OTC (£12,000), Mitochondrial disease (£10,261), Metabolic Liver Disease (£20,000) and Niemann Pick Type C disease (£8,000). The outcomes of Climb funded research projects have been numerous and far reaching and include the development of a new treatment for Glycolipid Storage Diseases, new patient monitoring systems for CAH and Tyrosinaemia sufferers, the development of improved treatment regimes for Cystinosis and PKU and a closer understanding of the biochemistry of Lactic Acidosis, Malonyl-CoA Decarboxylase Deficiency and Urea Cycle Disorders. Climb has funded projects ranging from those that have developed the basic understanding of cell biochemistry to those that have developed and evaluated new and better clinical treatments. All potential projects are assessed by a peer review process before being selected on merit by Climb’s research sub-committee. Projects approved for Grant by the Research Committee are referred to a full Board meeting at which Directors agree the funding of projects based upon the recommendations of the Research Sub-committee and available funding.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Climb Building, 176 Nantwich Road, Crewe. CW2 6BG. UK Climb Registered Charity No 1089588 |